Tristel Final Earnings Report

Tristel EPS Results

• Actual EPS: GBX 15.34
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Tristel Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Tristel Announcement Details

• Quarter: Final
• Date: 10/21/2024
• Time: Before Market Opens

Tristel (LON:TSTL) is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com